ARTICLE | Clinical News
Bardoxolone methyl regulatory update
April 27, 2015 7:00 AM UTC
FDA granted Orphan Drug designation to Reata’s bardoxolone to treat pulmonary arterial hypertension (PAH). The small molecule activator of nuclear factor (erythroid-derived 2)-like 2 ( NFE2L2; NRF2)...